All Cosmos Bio-Tech Holding Corporation reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was TWD 786.48 million compared to TWD 911.96 million a year ago. Revenue was TWD 786.48 million compared to TWD 911.96 million a year ago. Net income was TWD 38.87 million compared to TWD 94.34 million a year ago. Basic earnings per share from continuing operations was TWD 0.61 compared to TWD 1.47 a year ago. Diluted earnings per share from continuing operations was TWD 0.42 compared to TWD 1.47 a year ago.
For the six months, sales was TWD 1,564.45 million compared to TWD 1,577.61 million a year ago. Revenue was TWD 1,564.45 million compared to TWD 1,577.61 million a year ago. Net income was TWD 79.2 million compared to TWD 162.84 million a year ago. Basic earnings per share from continuing operations was TWD 1.24 compared to TWD 2.54 a year ago. Diluted earnings per share from continuing operations was TWD 1.18 compared to TWD 2.54 a year ago.